This website uses cookies to ensure you get the best experience on our website. Privacy Policy

REVIEW UroToday

Contact
Login
Sign Up Free

Transformative Evidence
- mCRPC
- mHSPC
  - ARANOTE Trial
  - ARASENS Trial
- nmCRPC
  - ARAMIS Trial
- nmCSPC
  - EMBARK Trial
- PSMA PET Imaging
- Bladder Cancer
Centers of Excellence
- Urologic Oncology
  - Left Group
    - Health Policy
      - Health Policy
        Ruchika Talwar, MD
    - Bladder Cancer
    - Kidney Cancer
      - Advanced Kidney Cancer
        Pedro Barata, MD, MSc
    - Endourology
      - Endourology
        Jaime Landman, MD
  - Prostate Cancer
  - Disparities: Social Determinants of Health
    - Disparities: Social Determinants of Health
      Samuel L. Washington III, MD, MAS
  - Translational Prostate Cancer
    - Translational Science in Prostate Cancer
      Andrea Miyahira, Ph.D
    - Women in Science
      Andrea Miyahira, Ph.D
  - Upper Tract Urothelial Carcinoma
    - Upper Tract Urothelial Carcinoma
      Sam S. Chang, MD, MBA
  - TESTICULAR, PENILE & RARE GU MALIGNANCIES
    - Testicular Cancer
- Pelvic Health & Reconstruction
Videos
- Exclusives
- Urologic Oncology
- Pelvic Health & Reconstruction
  - Pelvic Health & Reconstruction
Trials in Progress
- Trials in Progress
  - Bladder Cancer
    - IMMORTAL
    - PIVOT-006
  - Kidney Cancer
    - RadiCal
    - SAMURAI
- Middle Side
  - Prostate Cancer
- Right Side
  - Prostate Cancer
Clinical Trials
- From the Editor
  - Search Clinical Trials
Articles
- Urology (benign and malignant)
- Pelvic Health
  - Pelvic Health & Reconstruction
Conference Coverage
- Recent Conferences
- All Conferences
  - View All
- Quick Takes
  - ESMO 2024
PCF

UroToday Home
Browse Documents
uij volume 3
uij volume 3 issue 4

Prognostic Factors in Renal Cell Carcinoma With Vena Cava Extension

Download

About UroToday
Journals
Calendar
Editorial and Advertising Guidelines
Editors and Contributors
FAQs
Privacy Policy
Terms of Use

Prognostic Factors in Renal Cell Carcinoma With Vena Cava Extension

Login